Nuveen Asset Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.29M | Buy |
72,099
+47,889
| +198% | +$858K | ﹤0.01% | 2590 |
|
|
2024
Q3 | $390K | Sell |
24,210
-10,540
| -30% | -$170K | ﹤0.01% | 3089 |
|
|
2024
Q2 | $939K | Buy |
34,750
+18,406
| +113% | +$497K | ﹤0.01% | 2757 |
|
|
2024
Q1 | $319K | Hold |
16,344
| – | – | ﹤0.01% | 3090 |
|
|
2023
Q4 | $338K | Hold |
16,344
| – | – | ﹤0.01% | 3119 |
|
|
2023
Q3 | $520K | Sell |
16,344
-6,081
| -27% | -$193K | ﹤0.01% | 2838 |
|
|
2023
Q2 | $753K | Buy |
+22,425
| New | +$753K | ﹤0.01% | 2770 |
|
|
2022
Q2 | – | Sell |
-69,021
| Closed | -$3.02M | – | 3374 |
|
|
2022
Q1 | $3.02M | Sell |
69,021
-1,149
| -2% | -$50.3K | ﹤0.01% | 2314 |
|
|
2021
Q4 | $6.36M | Sell |
70,170
-2,481
| -3% | -$225K | ﹤0.01% | 1975 |
|
|
2021
Q3 | $9.7M | Buy |
72,651
+1,015
| +1% | +$136K | ﹤0.01% | 1805 |
|
|
2021
Q2 | $8.98M | Buy |
71,636
+9,808
| +16% | +$1.23M | ﹤0.01% | 1933 |
|
|
2021
Q1 | $8.39M | Buy |
61,828
+48,422
| +361% | +$6.57M | ﹤0.01% | 1892 |
|
|
2020
Q4 | $1.22M | Buy |
13,406
+4,308
| +47% | +$391K | ﹤0.01% | 2735 |
|
|
2020
Q3 | $677K | Buy |
9,098
+49
| +0.5% | +$3.65K | ﹤0.01% | 2846 |
|
|
2020
Q2 | $771K | Buy |
+9,049
| New | +$771K | ﹤0.01% | 2730 |
|